- Home
- LTRN vs DYAI Comparison
LTRN vs DYAI Comparison
Compare LTRN & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LTRN
- DYAI
- Stock Information
- Founded
- LTRN 2013
- DYAI 1979
- Country
- LTRN United States
- DYAI United States
- Employees
- LTRN N/A
- DYAI N/A
- Industry
- LTRN Biotechnology: Pharmaceutical Preparations
- DYAI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LTRN Health Care
- DYAI Health Care
- Exchange
- LTRN Nasdaq
- DYAI Nasdaq
- Market Cap
- LTRN 36.0M
- DYAI 30.2M
- IPO Year
- LTRN 2020
- DYAI 2004
- Fundamental
- Price
- LTRN $4.49
- DYAI $1.16
- Analyst Decision
- LTRN Strong Buy
- DYAI Strong Buy
- Analyst Count
- LTRN 1
- DYAI 1
- Target Price
- LTRN $25.00
- DYAI $6.00
- AVG Volume (30 Days)
- LTRN 197.2K
- DYAI 139.0K
- Earning Date
- LTRN 11-06-2025
- DYAI 11-11-2025
- Dividend Yield
- LTRN N/A
- DYAI N/A
- EPS Growth
- LTRN N/A
- DYAI N/A
- EPS
- LTRN N/A
- DYAI N/A
- Revenue
- LTRN N/A
- DYAI $4,135,078.00
- Revenue This Year
- LTRN N/A
- DYAI $34.23
- Revenue Next Year
- LTRN N/A
- DYAI $19.57
- P/E Ratio
- LTRN N/A
- DYAI N/A
- Revenue Growth
- LTRN N/A
- DYAI 129.20
- 52 Week Low
- LTRN $2.55
- DYAI $0.71
- 52 Week High
- LTRN $6.12
- DYAI $2.20
- Technical
- Relative Strength Index (RSI)
- LTRN 55.33
- DYAI 56.82
- Support Level
- LTRN $3.89
- DYAI $1.13
- Resistance Level
- LTRN $4.55
- DYAI $1.35
- Average True Range (ATR)
- LTRN 0.33
- DYAI 0.10
- MACD
- LTRN 0.02
- DYAI 0.00
- Stochastic Oscillator
- LTRN 79.22
- DYAI 50.16
About LTRN Lantern Pharma Inc.
Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.
About DYAI Dyadic International Inc.
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.